Literature DB >> 10218713

Attached posterior hyaloid membrane and the pathogenesis of honeycombed cystoid macular edema in patients with diabetes.

T Ikeda1, K Sato, T Katano, Y Hayashi.   

Abstract

PURPOSE: To investigate the pathogenesis of honeycombed cystoid macular edema in patients with diabetes.
METHODS: The relationship between the posterior hyaloid membrane and honeycombed cystoid macular edema was examined in 24 eyes of 20 patients with diabetes who underwent vitrectomy for cystoid macular edema.
RESULTS: In 19 eyes of 15 patients with diabetes, the posterior hyaloid membrane was attached to the macula, and in five eyes of five patients, the posterior hyaloid membrane was separated from the macula. In 14 (74%) of the 19 eyes with an attached posterior hyaloid membrane, honeycombed cystoid macular edema was detected. Conversely, honeycombed cystoid edema was not detected in any of the five eyes with posterior hyaloid detachment (P = .0059).
CONCLUSIONS: These observations demonstrate a strong correlation between an attached posterior hyaloid membrane and the presence of honeycombed cystoid macular edema. We suggest that retinal traction by the posterior hyaloid membrane is involved in the pathogenesis of honeycombed cystoid changes in diabetic patients.

Entities:  

Mesh:

Year:  1999        PMID: 10218713     DOI: 10.1016/s0002-9394(98)00382-1

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  8 in total

1.  Assessment of macular function by multifocal electroretinogram in diabetic macular edema before and after vitrectomy.

Authors:  Jin Ma; Ke Yao; Jiekai Jiang; Dezhen Wu; Rulong Gao; Jinfu Yin; Xiaoyun Fang
Journal:  Doc Ophthalmol       Date:  2004-09       Impact factor: 2.379

2.  A randomised controlled feasibility trial of vitrectomy versus laser for diabetic macular oedema.

Authors:  D Thomas; C Bunce; C Moorman; D A H Laidlaw
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

3.  Visual acuity comparison of vitrectomy with and without internal limiting membrane removal in the treatment of diabetic macular edema.

Authors:  Mehmet Bahadir; Aylin Ertan; Ozgür Mertoğlu
Journal:  Int Ophthalmol       Date:  2006-06-19       Impact factor: 2.031

Review 4.  Enzymatic vitrectomy for diabetic retinopathy and diabetic macular edema.

Authors:  Manuel Diaz-Llopis; Patricia Udaondo; Jose Maria Millán; J Fernando Arevalo
Journal:  World J Diabetes       Date:  2013-12-15

5.  Triple therapy: Phaco-vitrectomy with ILM peeling, retinal endophotocoagulation, and intraoperative use of bevacizumab for diffuse diabetic macular edema.

Authors:  Jacek Robaszkiewicz; Katarzyna Chmielewska; Małgorzata Figurska; Joanna Wierzbowska; Andrzej Stankiewicz
Journal:  Med Sci Monit       Date:  2012-04

6.  Diabetic macular edema: therapeutic options.

Authors:  Amol D Kulkarni; Michael S Ip
Journal:  Diabetes Ther       Date:  2012-03-06       Impact factor: 2.945

7.  Hyperreflective Membrane at the Vitreoretinal Interface in Diabetic Macular Edema: A Finding in Ultra-High-Resolution Optical Coherence Tomography.

Authors:  Iori Wada; Shintaro Nakao; Mitsuru Arima; Keijiro Ishikawa; Muneo Yamaguchi; Yoshihiro Kaizu; Haruka Sekiryu; Kenichiro Mori; Kohei Kiyohara; Atsunobu Takeda; Tatsuro Ishibashi; SriniVas R Sadda; Koh-Hei Sonoda
Journal:  Transl Vis Sci Technol       Date:  2022-09-01       Impact factor: 3.048

Review 8.  Diabetic retinopathy: an update.

Authors:  Ramandeep Singh; Kim Ramasamy; Chandran Abraham; Vishali Gupta; Amod Gupta
Journal:  Indian J Ophthalmol       Date:  2008 May-Jun       Impact factor: 1.848

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.